Autolomous’ Post

View organization page for Autolomous, graphic

2,413 followers

New advancements at Universitätsklinikum Erlangen bring new possibilities for treating severe lupus nephritis, a critical kidney complication of systemic lupus erythematosus (SLE). A recent case study details the recovery of a 15-year-old patient who, after receiving CD19-targeted CAR T-cell therapy, was freed from hemodialysis and showed significant improvements in kidney function and overall health. This innovative therapy, previously successful in adult patients with refractory SLE, now demonstrates its potential in adolescents. Published in a recent medical journal, this represents a significant step forward in the treatment of autoimmune diseases, showcasing the transformative potential of CAR T-cell therapy for severe lupus nephritis. #AutoimmuneDisease #LupusNephritis #CARTherapy #MedicalResearch #Innovation #UniversityHospitalErlangen

To view or add a comment, sign in

Explore topics